ArticleMolecular medicine reports2020

TBOPP enhances the anticancer effect of cisplatin by inhibiting DOCK1 in renal cell carcinoma.

Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.